Evaluation of Women's Experience With EVRA (Norelgestromin + Ethinyl Estradiol) Transdermal Contraceptive Patch Compared With Previous Methods of Contraception.
PHASE4CompletedINTERVENTIONAL
Enrollment
778
Participants
Timeline
Start Date
July 31, 2003
Study Completion Date
December 31, 2004
Conditions
ContraceptionFemale Contraception
Interventions
DRUG
norelgestromin + ethinyl estradiol
All Listed Sponsors
lead
Janssen Pharmaceutica N.V., Belgium
INDUSTRY
NCT00261482 - Evaluation of Women's Experience With EVRA (Norelgestromin + Ethinyl Estradiol) Transdermal Contraceptive Patch Compared With Previous Methods of Contraception. | Biotech Hunter | Biotech Hunter